Opus Genetics
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8 Davis Dr Ste 220, Durham, North Caroli...Phone Number
(984) 884-6030Website
www.opusgtx.comRevenue
$9.9 MillionStock Symbol
IRDIndustry
About Opus Genetics
Opus Genetics is a clinical-stage biopharmaceutical company in the biotechnology and ophthalmology industry, focused on developing innovative gene therapies for inherited retinal diseases and other retinal and refractive disorders. Headquartered in the United States, the company conducts research and development in ophthalmic gene therapies and is dedicated to creating treatments that correct or compensate for genetic defects causing retinal degeneration. Opus Genetics aims to deliver durable, vision-preserving and vision-restoring therapies, translating scientific breakthroughs into safe and effective solutions for patients with rare and common retinal conditions, while striving to lead global innovation in ophthalmic gene therapy.Explore more
Opus Genetics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Opus Genetics
Compare insights from companies similar to Opus Genetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Opus Genetics Tech Stack
A closer look at the technologies used by Opus Genetics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Opus Genetics
Sign Up For FreeTo access detailed company insights
Opus Genetics is a clinical-stage biopharmaceutical company in the biotechnology and ophthalmology industry, focused on developing innovative gene therapies for inherited retinal diseases and other retinal and refractive disorders. Headquartered in the United States, the company conducts research and development in ophthalmic gene therapies and is... Read More
